RBOT

SEC source: 0001213900-22-033363 · ownership.xml · nonDerivative · entry 2

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,049,408

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.180 to $3.245 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-033363 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,053,959

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

SEC source: 0001213900-22-031756 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,258,113

F1 · price: This figure is the weighted average sales price of multiple trades ranging from $4.515 to $4.595 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-031145 · ownership.xml · nonDerivative · entry 1

Ho David D · CIK 0001850976 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,944

F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-22-031148 · ownership.xml · nonDerivative · entry 1

Tang Donald F · CIK 0001817370 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,740

F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-22-031149 · ownership.xml · nonDerivative · entry 1

Fulop Ric · CIK 0001472305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,655

F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-22-031151 · ownership.xml · nonDerivative · entry 1

Kaul Samir · CIK 0001501915 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,570

F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-22-031150 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,278,113

F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-22-031146 · ownership.xml · nonDerivative · entry 1

Styka David Michael · CIK 0001884339 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,655

F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-22-031142 · ownership.xml · nonDerivative · entry 1

Berman Dror · CIK 0001883780 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,740

F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-22-030681 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,240,082

F1 · price: This figure is the weighted average sales price of multiple trades ranging from $4.040 to $4.404 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-030433 · ownership.xml · derivative · entry 3

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,307,037

Underlying: Class A Common Stock · 11,329 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F1 · derivative.exercise_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F1 · derivative.expiration_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

SEC source: 0001213900-22-030433 · ownership.xml · nonDerivative · entry 2

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,311,771

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.98 to $4.14 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-030433 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,323,100

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

SEC source: 0001213900-22-028598 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 350,428

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in 16 equal quarterly installments over the four years following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-22-028586 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,311,771

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in 16 equal quarterly installments over the four years following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-22-028592 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, Gen.Counsel & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 346,565

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in 16 equal quarterly installments over the four years following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-22-028594 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,049,408

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in 16 equal quarterly installments over the four years following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date.

SEC source: 0001213900-22-027699 · ownership.xml · derivative · entry 3

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,542,566

Underlying: Class A Common Stock · 4,551 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F1 · derivative.exercise_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F1 · derivative.expiration_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

SEC source: 0001213900-22-027699 · ownership.xml · nonDerivative · entry 2

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,413

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.645 to $3.980 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-027699 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,964

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

SEC source: 0001213900-22-027062 · ownership.xml · nonDerivative · entry 2

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,268,082

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.55 to $3.93 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-027062 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,297,282

F1 · price: This figure is the weighted average sales price of multiple trades ranging from $3.54 to $3.61 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-023278 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Chelvey International Limited

Disclosed balance after: 43,888

F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners on a pro rata basis, for no consideration.

F2 · ownership.nature: Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-22-022280 · ownership.xml · derivative · entry 3

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,318,366

Underlying: Class A Common Stock · 11,329 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F1 · derivative.exercise_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F1 · derivative.expiration_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

SEC source: 0001213900-22-022280 · ownership.xml · nonDerivative · entry 2

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,527

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $4.23 to $4.43 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-022280 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 181,856

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

SEC source: 0001213900-22-020859 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By E15 Fund Advisors (HK) Limited

Disclosed balance after: 330,001

F1 · kind: E15 Fund Advisors (HK) Limited distributed these shares to its members, on a pro rata basis, for no consideration.

F2 · ownership.nature: Shares held directly by E15 Fund Advisors (HK) Limited. The Reporting Person, as the managing partner of E15 Fund Advisors (HK) Limited, may be deemed to share voting and dispositive power over the shares held by E15 Fund Advisors (HK) Limited. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund Advisors (HK) Limited, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-22-020614 · ownership.xml · derivative · entry 3

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,547,117

Underlying: Class A Common Stock · 4,551 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and has no expiration date.

F1 · derivative.exercise_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and has no expiration date.

F1 · derivative.expiration_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and has no expiration date.

SEC source: 0001213900-22-020614 · ownership.xml · nonDerivative · entry 2

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,413

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

SEC source: 0001213900-22-020614 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,964

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and has no expiration date.

SEC source: 0001213900-22-019902 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,413

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $4.05 to $4.21 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-018661 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,555

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

SEC source: 0001213900-22-018522 · ownership.xml · nonDerivative · entry 4

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,308,799

F3 · kind: E15 Fund Advisors (HK) Limited distributed these shares to its members, including the Reporting Person, on a pro rata basis, for no consideration.

SEC source: 0001213900-22-018522 · ownership.xml · nonDerivative · entry 3

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By E15 Fund Advisors (HK) Limited

Disclosed balance after: 856,180

F3 · kind: E15 Fund Advisors (HK) Limited distributed these shares to its members, including the Reporting Person, on a pro rata basis, for no consideration.

F4 · ownership.nature: Shares held directly by E15 Fund Advisors (HK) Limited. The Reporting Person, as the managing partner of E15 Fund Advisors (HK) Limited, may be deemed to share voting and dispositive power over the shares held by E15 Fund Advisors (HK) Limited. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund Advisors (HK) Limited, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-22-018522 · ownership.xml · nonDerivative · entry 2

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By E15 Fund Advisors (HK) Limited

Disclosed balance after: 2,053,928

F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners, including E15 Fund Advisors (HK) Limited, on a pro rata basis, for no consideration.

F4 · ownership.nature: Shares held directly by E15 Fund Advisors (HK) Limited. The Reporting Person, as the managing partner of E15 Fund Advisors (HK) Limited, may be deemed to share voting and dispositive power over the shares held by E15 Fund Advisors (HK) Limited. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund Advisors (HK) Limited, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-22-018522 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Chelvey International Limited

Disclosed balance after: 176,883

F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners, including E15 Fund Advisors (HK) Limited, on a pro rata basis, for no consideration.

F2 · ownership.nature: Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-22-024037 · ownership.xml · nonDerivative · entry 2

Ho David D · CIK 0001850976 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,913

F2 · price: RSUs granted to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of $10,625 of cash retainer fees earned during the first quarter of 2022. The RSUs were fully vested on the grant date.

SEC source: 0001213900-22-024035 · ownership.xml · nonDerivative · entry 2

Kaul Samir · CIK 0001501915 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,539

F2 · price: RSUs granted to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of $12,700 of cash retainer fees earned during the first quarter of 2022. The RSUs were fully vested on the grant date.

SEC source: 0001213900-22-024032 · ownership.xml · nonDerivative · entry 2

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,312,282

F2 · price: RSUs granted to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of $11,550 of cash retainer fees earned during the first quarter of 2022. The RSUs were fully vested on the grant date.

SEC source: 0001213900-22-015901 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,527

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

SEC source: 0001213900-22-015903 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, Gen.Counsel & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,052

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

SEC source: 0001213900-22-014597 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Chelvey International Limited

Disclosed balance after: 2,010,608

F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners on a pro rata basis, for no consideration.

F2 · ownership.nature: Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-22-014602 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,865

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

SEC source: 0001213900-22-014593 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 179,064

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

SEC source: 0001213900-22-014595 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, Gen. Counsel & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,337

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

SEC source: 0001213900-22-014600 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,243

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

SEC source: 0001213900-22-014597 · ownership.xml · nonDerivative · entry 2

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Chelvey International Limited

Disclosed balance after: 2,063,806

F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners on a pro rata basis, for no consideration.

F2 · ownership.nature: Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-22-013929 · ownership.xml · nonDerivative · entry 2

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 301,699

F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partner, Mr. Liang, on a pro rata basis, for no consideration.

F3 · balance_after: Consists of (i) 265,990 shares of Class A Common Stock held by Mr. Liang and (ii) 35,709 restricted stock units ("RSUs") held by Mr. Liang. Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 36 equal monthly installments beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Mr. Liang's continued service through the applicable vesting date.

SEC source: 0001213900-22-013929 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Chelvey International Limited

Disclosed balance after: 2,123,654

F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partner, Mr. Liang, on a pro rata basis, for no consideration.

F2 · ownership.nature: Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein.